S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Bed Bath & Beyond Is Circling the Drain
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
NASDAQ:PHAR

Pharming Group - PHAR Stock Forecast, Price & News

$13.45
+0.08 (+0.60%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
$13.45
$14.16
50-Day Range
$10.56
$14.78
52-Week Range
$6.10
$15.00
Volume
8,468 shs
Average Volume
3,524 shs
Market Capitalization
$878.02 million
P/E Ratio
32.81
Dividend Yield
N/A
Price Target
N/A

PHAR stock logo

About Pharming Group (NASDAQ:PHAR) Stock

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre-eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Receive PHAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

PHAR Stock News Headlines

Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Pharming to present at Jefferies Healthcare Conference
Pharming to present at Stifel Healthcare Conference
Are Medical Stocks Lagging Lantheus (LNTH) This Year?
Pharming Group N.V.: Pharming Group Notice of Q3 Results
European Shares Slump As Risk Appetite Wanes
Pharming Group Notice of H1 2022 Results
See More Headlines
Receive PHAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

PHAR Company Calendar

Today
2/02/2023
Next Earnings (Estimated)
3/16/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PHAR
Fax
N/A
Employees
262
Year Founded
N/A

Profitability

Net Income
$16 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$198.87 million
Cash Flow
$0.55 per share
Book Value
$2.97 per share

Miscellaneous

Free Float
63,929,000
Market Cap
$878.02 million
Optionable
Not Optionable
Beta
0.22

Key Executives

  • Dr. Sijmen de Vries M.B.A. (Age 63)
    M.D., MBA, Pres, CEO & Exec. Director
    Comp: $1.2M
  • Dr. Bruno M. L. Giannetti (Age 70)
    Consultant
  • Mr. Jeroen Wakkerman (Age 53)
    Chief Financial Officer
  • Ms. Mireille Sanders M.Sc. (Age 54)
    Chief Operations Officer
  • Susanne Embleton
    Investor Relations Mang.
  • Mr. Ruud Van Outersterp (Age 58)
    Chief Ethics & Compliance Officer
  • Mr. Anurag Relan (Age 50)
    Chief Medical Officer
  • Mr. Stephen Toor (Age 51)
    Chief Commercial Officer & GM of Americas













PHAR Stock - Frequently Asked Questions

How have PHAR shares performed in 2023?

Pharming Group's stock was trading at $11.03 at the beginning of 2023. Since then, PHAR stock has increased by 21.9% and is now trading at $13.45.
View the best growth stocks for 2023 here
.

When is Pharming Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 16th 2023.
View our PHAR earnings forecast
.

What is Pharming Group's stock symbol?

Pharming Group trades on the NASDAQ under the ticker symbol "PHAR."

Who are Pharming Group's major shareholders?

Pharming Group's stock is owned by many different institutional and retail investors. Top institutional investors include Cowen Prime Advisors LLC (0.03%).

How do I buy shares of Pharming Group?

Shares of PHAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharming Group's stock price today?

One share of PHAR stock can currently be purchased for approximately $13.45.

How much money does Pharming Group make?

Pharming Group (NASDAQ:PHAR) has a market capitalization of $878.02 million and generates $198.87 million in revenue each year. The company earns $16 million in net income (profit) each year or $0.41 on an earnings per share basis.

How many employees does Pharming Group have?

The company employs 262 workers across the globe.

How can I contact Pharming Group?

Pharming Group's mailing address is DARWINWEG 24, LEIDEN P7, 2333 CR. The official website for the company is www.pharming.com. The company can be reached via phone at 31-71-524-7400 or via email at investor@pharming.com.

This page (NASDAQ:PHAR) was last updated on 2/2/2023 by MarketBeat.com Staff